# Biomarkers of Muscle Anabolism (MK-0000-082)

> **NCT00812396** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 30 (actual)

## Conditions studied

- Muscle Anabolism

## Interventions

- **DRUG:** Comparator: low dose testosterone
- **DRUG:** Comparator: high dose testosterone
- **DRUG:** Comparator: placebo

## Key facts

- **NCT ID:** NCT00812396
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00812396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00812396, "Biomarkers of Muscle Anabolism (MK-0000-082)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00812396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*